Madison (MDEX) 10-Q 27 Mar 24 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	Mar. 27, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-51302
Entity Registrant Name	Madison Technologies Inc.
Entity Central Index Key	0001318268
Entity Tax Identification Number	85-2151785
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2500 Westchester Avenue
Entity Address, City or Town	Purchase
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10577
City Area Code	(212)
Local Phone Number	257-4193
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,603,095,243

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 593
Prepaid expenses		12,722
Assets from discontinued operations		11,726,332
Total Current Assets	593	11,739,054
Investments		100
Total Assets	593	11,739,154
CURRENT LIABILITIES
Accounts payable and accrued expenses	960,994	741,399
Derivative liability	4,429,329	4,429,329
Promissory notes	1,061,415	936,112
Convertible notes	2,283,297	1,883,295
Interest payable on senior secured notes	3,753,750	3,300,000
Senior secured notes, net of discount	15,013,449	14,599,240
Liabilities from discontinued operations		2,582,902
Total current liabilities	27,502,234	28,472,277
Capital Stock:
Common Shares - $0.001 par value; 6,000,000,000 shares authorized, 1,603,095,243 shares issued and outstanding, March 31, 2023 and December 31, 2022, respectively	1,603,095	1,603,095
Additional paid in capital	10,549,165	10,549,265
Accumulated deficit	(39,655,249)	(28,886,831)
Total stockholders’ deficit	(27,502,989)	(16,734,471)
Total liabilities and stockholders’ deficit	593	11,739,154
Series C Preferred Stock [Member]
CURRENT LIABILITIES
Temporary equity value
Series D Preferred Stock [Member]
CURRENT LIABILITIES
Temporary equity value	155	155
Series E Preferred Stock [Member]
CURRENT LIABILITIES
Temporary equity value
Series E-1 Preferred Stock [Member]
CURRENT LIABILITIES
Temporary equity value	1,153	1,153
Series F Preferred Stock [Member]
CURRENT LIABILITIES
Temporary equity value
Series G Preferred Stock [Member]
CURRENT LIABILITIES
Temporary equity value
Series H Preferred Stock [Member]
CURRENT LIABILITIES
Temporary equity value	40	40
Series A Preferred Stock [Member]
Capital Stock:
Preferred Stock value
Series B Preferred Stock [Member]
Capital Stock:
Preferred Stock value

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred Stock, Shares Authorized	50,000,000	50,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	6,000,000,000	6,000,000,000
Common stock, shares issued	1,603,095,243	1,603,095,243
Common stock, shares outstanding	1,603,095,243	1,603,095,243
Series E-1 Preferred Stock [Member]
Temporary equity, at par value	$ 0.001	$ 0.001
Temporary equity, stated value	$ 0.87	$ 0.87
Temporary equity, shares authorized	1,152,500	1,152,500
Temporary Equity, Shares Issued	1,152,500	1,152,500
Temporary Equity, Shares Outstanding	1,152,500	1,152,500
Series F Preferred Stock [Member]
Temporary equity, at par value	$ 0.001	$ 0.001
Temporary equity, stated value	$ 1	$ 1
Temporary equity, shares authorized	1,000	1,000
Temporary Equity, Shares Issued	0	0
Temporary Equity, Shares Outstanding	0	0
Temporary equity, shares converted	1,000	1,000
Series G Preferred Stock [Member]
Temporary equity, at par value	$ 0.001	$ 0.001
Temporary equity, stated value	$ 1,000	$ 1,000
Temporary equity, shares authorized	4,600	4,600
Temporary Equity, Shares Issued	0	0
Temporary Equity, Shares Outstanding	0	0
Temporary equity, shares converted	4,600	4,600
Series H Preferred Stock [Member]
Temporary equity, at par value	$ 0.001	$ 0.001
Temporary equity, stated value	$ 1	$ 1
Temporary equity, shares authorized	39,895	39,895
Temporary Equity, Shares Outstanding	39,895	39,895

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenues
Operating Expenses
Selling, general and administrative	350,830	44,502
Professional fees	107,740	663,805
Total operating expenses	458,570	708,307
Loss before other expense	(458,570)	(708,307)
Other income (expenses)
Other income		9,381
Loss on disposition of assets	(15,859,990)
Interest expense	(1,135,202)	(1,520,001)
Total other expense	(16,995,192)	(1,510,620)
Loss from continuing operations	(17,453,762)	(2,218,927)
Income (loss) from discontinued operations	6,685,344	(317,761)
Net loss and comprehensive loss	$ (10,768,418)	$ (2,536,688)
Net loss per share-Basic and diluted	$ (0.006)	$ (0.002)
Average number of shares of common stock outstanding	1,603,095,243	1,599,095,027

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 1,599,095	$ 10,473,261	$ (15,747,021)	$ (3,674,665)
Beginning balance (in shares) at Dec. 31, 2021	1,599,095,027
Net loss for the period			(2,536,688)	(2,536,688)
Ending balance, value at Mar. 31, 2022	$ 1,599,095	10,473,261	(18,283,709)	6,211,353
Ending balance (in shares) at Mar. 31, 2022	1,599,095,027
Beginning balance, value at Dec. 31, 2022	$ 1,603,095	10,549,265	(28,886,831)	(16,734,471)
Beginning balance (in shares) at Dec. 31, 2022	1,603,095,243
Net loss for the period		(100)	(10,768,418)	(10,768,518)
Ending balance, value at Mar. 31, 2023	$ 11,603,095	$ 10,549,165	$ (39,655,249)	$ (27,502,989)
Ending balance (in shares) at Mar. 31, 2023	1,603,095,243

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss from continuing operations for the period	$ (17,453,762)	$ (2,218,927)
Adjustments to reconcile net loss to cash used in operating activities:
Amortized interest	699,516	652,933
Amortization
Fair value of Warrant issued for services		9,000
Loss on disposal of assets	15,874,921
Changes in assets and liabilities:
Accounts payable and accruals	673,343	354,976
Payment of lease liability
Accounts receivable
Due from related party
Prepaid expenses	12,722	13,317
Net cash used in operating activities	(193,260)	(1,188,701)
Cash flows from investing activities:
Purchases of equipment, intangible assets and goodwill		(30,427)
Funds advanced for note receivable		(51,517)
Net cash used in investing activities		(81,944)
Cash flows from financing activities:
Proceeds from convertible and subordinate notes sold	240,000	810,000
Net cash provided by financing activities	240,000	810,000
Cash flows from continuing operations	46,740	(460,645)
Cash flows from discontinued operations:
Net cash provided by (used in) operating activities	(46,147)	474,446
Net cash used in investing activities		(14,514)
Cash flows from discontinued operations	(46,147)	459,932
Net (decrease) increase in cash	593	(713)
Cash, beginning of period		729
Cash, end of period	593	16
SUPPLEMENTAL DISCLOSURE
Interest paid		453,750
Taxes paid

Nature of Operations

Nature of Operations	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Note 1 Nature of Operations Madison Technologies Inc. (“Madison” or the “Company” or “we” or “us” or “our”) was incorporated on June 15, 1998 in the State of Nevada, and our shares of common stock, par value $0.001 per share (“Common Stock”), are quoted on the Experts Market tier of the over-the-counter market operated by OTC Markets, Inc. We are seeking to create, develop and launch BlockchainTV (“BCTV”), the first-to-market 24/7 television broadcast and streaming communications network designed to bring the most up-to-date crypto information and entertainment to the masses in the U.S. and around the world.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2 Going Concern The accompanying condensed consolidated financial statements have been prepared assuming we will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. For the year ended December 31, 2022, we generated no revenues from continuing operations, incurred a net loss of $ 13,139,810 13,860,314 28,886,831

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3 Summary of Significant Accounting Policies Use of estimates The preparation of the condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates. Consolidation The accompanying condensed consolidated financial statements include the accounts of our current and former wholly owned subsidiaries, Blockchain.tv, Inc. and SovRryn Holdings Inc. (“Sovryn”). Sovryn is consolidated up until January 31, 2023 and recognized as a discontinued operation. All the intercompany balances and transactions have been eliminated in the consolidation. Interim Reporting While the information presented in the accompanying interim three-month financial statements is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. These interim financial statements follow the same accounting policies and methods of their application as the Company’s December 31, 2022 annual financial statements. All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Company’s December 31, 2022 annual financial statements. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that can be expected for the year ended December 31, 2023. Segment reporting Our chief operating decision maker is our chief executive officer, who reviews information on an aggregated basis. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation. Revenue recognition We adopted the ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). We recognize revenue when we transfer promised services to the customer. The performance obligation is the monthly services rendered. We have one main revenue source which is leasing of television station channels. Accordingly, we recognize revenue when services are provided as time passes the customers have access to utilize the channel. These revenues are billed in advance, arrears and/or are prepaid. The performance obligation is the monthly services rendered. At March 31, 2023, we have one main revenue source, which is the leasing of television channels. Where there is a leasing contract for channels, we bill monthly for our services as rendered. Where there is no contract, the revenue is recognized as provided. We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues: ● identify the contract with a customer; ● identify the performance obligations in the contract; ● determine the transaction price; ● allocate the transaction price to performance obligations in the contract; and ● recognize revenue as the performance obligation is satisfied. Advances from client deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from client deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract. Impairment of Long-Lived Assets In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets ” Financial instruments Our financial instruments consist principally of accounts payable, accrued liabilities and notes payable. The carrying amounts of such financial instruments in the accompanying financial statements approximate their fair values due to their relatively short-term nature or the underlying terms are consistent with market terms. It is the management’s opinion that we are not exposed to any significant currency or credit risks arising from these financial instruments. Fair value measurements We follow the guidelines in ASC Topic 820 “Fair Value Measurements and Disclosures”. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. All financial instruments approximate their fair value. Level 1 — Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets. Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3—inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Convertible Notes with Fixed Rate Conversion Options We may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. We record the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the note date with a charge to interest expense in accordance with ASC 480–- “Distinguishing Liabilities from Equity”. Derivative Liabilities We have certain financial instruments that are derivatives or contain embedded derivatives. We evaluate all of our financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 810-10-05-4 and 815-40. This accounting treatment requires that the carrying amount of any derivatives be recorded at fair value at issuance and marked-to-market at each balance sheet date. In the event that the fair value is recorded as a liability, as is the case with us, the change in the fair value during the period is recorded as either other income or expense. Upon conversion, exercise or repayment, the respective derivative liability is marked to fair value at the conversion, repayment or exercise date and then the related fair value amount is reclassified to other income or expense as part of gain or loss on extinguishment. Loss per share Net Loss Per Share Basic loss per share is calculated by dividing the loss attributable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in our earnings (loss). Diluted loss per share is computed by dividing the loss available to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless such dilutive potential shares would result in anti-dilution. As of March 31, 2023 and 2022, no options were outstanding and 286,173,016 203,673,016 22,154,828 19,383,713 1,187,237,384 951,018,661 318,056,580 155,000,000 1,152,500,000 39,895,000 3,138,861,880 2,501,586,677 the number of shares converted into either 4.99% or 9.99% of the then outstanding shares. Schedule of Potentially Dilutive Securities March 31, 2023 March 31, 2022 Warrants 286,173,016 203,673,016 Convertible Preferred Stock 1,665,451,580 1,346,895,000 Convertible debt 1,187,237,384 951,018,661 Total 3,136,861,880 2,501,586,677 Related Party Transactions We follow FASB ASC subtopic 850-10, “Related Party Transactions”, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: (a) our affiliates; (b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; (d) our principal owners; ©) our management; (f) other parties with which we may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Material related party transactions are required to be disclosed in the condensed consolidated financial statements, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. Discontinued operations Discontinued operations are components of an entity that either have been disposed or abandoned or is classified as held for sale. Additionally, in order to qualify as a discontinued operation, the disposal or abandonment must represent a strategic shift that has or will have a major effect on an entity’s operations and financial results. Income taxes We follow the guideline under ASC Topic 740 Income Taxes. “Accounting for Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Due to the uncertainty regarding our future profitability, the future tax benefits of its losses have been fully reserved. Recently Issued Accounting Pronouncements We adopt new pronouncements relating to generally accepted accounting principles applicable to us as they are issued, which may be in advance of their effective date. We do not believe that any recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying condensed consolidated financial statements.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Note 2 Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities are summarized below: March 31, 2023 December 31, 2022 Accounts payable $ 385,797 $ 371,987 Accrued expenses 293,210 174,078 Accrued interest 281,988 195,334 Total $ 960,994 $ 741,399

Derivative Liability

Derivative Liability	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability	Note 3 Derivative Liability We incur a derivative liability when we issue warrants in connection with the sale of notes payable. Management has determined that the daily closing price of our Common Stock is not a reliable factor for determining the value of the warrants and corresponding derivative liability on the basis that (i) the total volume of our Common Stock traded is approximately 3,700,000 shares since January 1, 2023, representing 0.2% of our outstanding shares and (ii) since July 2022 through the date of this Quarterly Report on form 10-Q, our Common Stock is listed on the OTC Expert Market that limits visibility of our Common Stock to investors. Valuation methods such at Black-Scholes rely on daily closing prices and their volatility. As a better representation of value, management used a share price of $0.018 per share to determine the derivative liability from warrants issued through December 31, 2022, which was the per share price used in connection with the issuance of 255,555,556 shares of Common Stock issued upon conversion of the Series G Preferred Stock on November 2, 2021. For the three months ended March 31, 2023, our derivative liability was as follows: Schedule of Derivative Liability March 31, 2023 Balance at January 1, 2023 $ 4,429,329 Liability for Warrants issued — Balance at March 31, 2023 $ 4,429,329 In the three months ended March 31, 2023, we issued warrants to purchase up to 40,000,000 0.02

Promissory Notes

Promissory Notes	3 Months Ended
	Mar. 31, 2023
Promissory Notes
Promissory Notes	Note 4 Promissory Notes On December 28, 2021, we issued a $ 500,000 12 March 31, 2023 500,000 December 31, 2023 0.025 9,000 0.018 convertible notes having an aggregate principal amount of $16.5 million (collectively, the “ funds affiliated with Arena Investors, LP (collectively, 500,000 On January 14, 2022, we issued an unsecured $ 150,000 15,000 April 5, 2022 120,000 On January 14, 2022, we issued an unsecured $ 150,000 15,000 April 5, 2022 135,000 On April 27, 2022, we issued a $ 125,000 12,500 December 31, 2022 2,500,000 0.025 45,000 0.018 125,000

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2023
Convertible Notes Payable
Convertible Notes Payable	Note 5 Convertible Notes Payable Our convertible notes payable, all of which are current liabilities, are as follows as of: Schedule of Convertible Notes Payable March 31, December 31, Series 1 (a) 1,050,000 1,050,000 Series 2 (b) 470,000 250,000 Series 3 (c) 208,000 208,000 Series 4 (d) 220,000 550,000 Series 5 (e) 542,500 192,500 Series 6 (f) 55,000 55,000 Principal outstanding 2,545,500 2,305,500 Less discount 262,203 426,094 Principal outstanding, net $ 2,283,297 $ 1,879,406 (a) Series 1: We issued a total of $ 1,050,000 6 December 31, 2022 0.021 (b) Series 2: On January 6, 2022, we issued to one of our shareholders a $ 250,000 12 April 6, 2022 6,250,000 0.021 112,500 0.018 On January 14, 2022, we issued to one of our shareholders a $ 25,000 12 600,000 0.021 10,800 0.018 On February 17, 2022, we issued a $ 50,000 12 April 6, 2022 1,250,000 0.021 22,500 0.018 (c) Series 3: On February 15, 2022, we issued two $ 137,500 11.25 February 23, 2023 15,000 2,500,000 0.10 90,000 0.018 0.02 67,000 13,004 (d) Series 4: On May 5, 2022, we issued a shareholder a convertible subordinate note totaling $ 110,000 12 May 5, 2023 0.02 5,000,000 0.02 On June 24, 2022, we issued a convertible subordinate note totaling $ 110,000 12 May 5, 2023 0.02 5,000,000 0.02 (e) Series 5: On May 5, 2022, we issued an $ 82,500 7,500 May 5, 2023 12 3,750,000 0.02 67,500 0.018 82,500 On May 5, 2022, we issued a $ 110,000 10,000 May 5, 2023 12 5,000,000 0.02 90,000 0.018 110,000 On October 14, 2022, we issued a $ 110,000 10,000 October 14, 2023 12 5,000,000 0.02 90,000 0.018 110,000 On December 2, 2022, we issued a $ 220,000 20,000 October 14, 2023 12 10,000,000 0.02 180,000 0.018 220,000 (f) Series 6: On September 16, 2022, we issued a $ 55,000 5,000 September 16, 2023 12 0.001 55,000 On February 17, 2022, we issued a $ 50,000 12 April 6, 2022 1,250,000 0.021 22,500 0.018

Senior Secured Notes

Senior Secured Notes	3 Months Ended
	Mar. 31, 2023
Senior Secured Notes
Senior Secured Notes	Note 6 Senior Secured Notes On February 17, 2021, we entered into a securities purchase agreement with the Investors pursuant to which we issued the Notes. The Notes are secured by a blanket lien on all of the Company’s assets and the shares of our Common Stock and Preferred Stock (the “Pledged Assets”) held by Philip Falcone, FFO1 2021 Irrevocable Trust, FFO2 2021 Irrevocable Trust and Korr Value LP (the “Pledgors”), which shares may be voted by the Investors in the event of default. In connection with the issuance of the Notes, we issued to the Investors warrants to purchase an aggregate of 192,073,017 1,000 192,073,017 864,000 0.0045 The Notes have a term of thirty-six months and mature on February 17, 2024, unless earlier converted. The Notes accrue interest at a rate of 11 3,619,000 3,300,000 On September 24, 2021, the Company and the Investors amended the Notes and related closing documents, by executing the Limited Waiver and First Amendment the closing documents. Such amendment also waived specified events of default. The Notes were henceforth convertible at any time, at the holder’s option, into shares of our Common Stock at a price of $ 0.02 As part of such purchase agreement with the Investors, we issued warrants to purchase up to 192,073,017 0.025 0.020 The Series F Preferred Stock has no voting rights and converts into 4.9% of our issued and outstanding shares of our Common Stock on a fully diluted basis upon the date on which stockholder approval for such issuance is obtained. 192,073,017 On October 27, 2022, the agent (the “Agent”) for the Investors notified us that certain events of default have occurred and were continuing under the Notes. On November 21, 2022, we, the Investors and the Agent entered into a Forbearance Agreement, pursuant to which, among other things, we acknowledged the outstanding principal balances of the Notes, that we have an obligation for interest, including default interest, fees and expenses in connection with the Notes, that we have no rights of offset, defenses, claims or counterclaims with respect to our obligations and pursuant to a side letter, dated as of November 21, 2022, we agreed to achieve certain milestones by the dates as set forth therein. The Forbearance Agreement expired on December 30, 2022. As of March 31, 2023 and December 31, 2022, the outstanding liability for the Notes is as follows: Schedule of senior secured Note March 31, December 31, Principal $ 16,500,000 $ 16,500,000 Less discount 1,486,551 1,900,760 Principal, net of discount $ 15,013,449 $ 14,599,240 As of March 31, 2023 and December 31, 2022, accrued interest payable was $ 3,753,750 3,300,000

Related Party

Related Party	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party	Note 7 Related Party Effective January 1, 2022, we entered into a management consulting agreement with GreenRock LLC, a company controlled by Philip Falcone, for a period of one year ending December 31, 2022, under which we provided monthly remuneration of $ 35,000 35,000 40,000 128,473 233,140

Mezzanine Equity

Mezzanine Equity	3 Months Ended
	Mar. 31, 2023
Mezzanine Equity
Mezzanine Equity	Note 8 Mezzanine Equity We account for certain of our Preferred Stock in accordance with the guidance in ASC Topic 480, Distinguishing Liabilities from Equity Preferred Shares Series A Preferred Stock There are 100,000 9.99 3,420 360,000,000 On July 17, 2020, we issued 92,999 343,094 the acquisition cost derived using the $0.04 market price on that date of $0.04 multiplied by 95% of the number of our issued and outstanding shares at the time (18,057,565) and multiplied by 50% of that value. As at March 31, 2023, no shares of Series A Preferred Stock are outstanding. Series C Preferred Stock There are 10,000 9.99 Holders of Series C Preferred Stock are entitled to receive, when and as declared, dividends equal to 2% per annum on the stated value, payable in additional shares of Series C Preferred Stock. So long as any shares of Series C Preferred Stock remain outstanding, without the consent of the holders of 80% of the shares of Series C Preferred Stock then outstanding, we may not redeem, repurchase or otherwise acquire directly or indirectly any securities deemed junior to such Series C Preferred Stock (“Junior Securities”) nor may we directly or indirectly pay or declare or make any distribution upon, nor may any distribution be made in respect of, any Junior Securities 100 Series D Preferred Stock There are 230,000 4.99 9.99 3.32 1,000 On February 16, 2021, we settled $ 1,028,000 230,000 75,000 75,000,000 155,000 Series E Preferred Stock There are 1,000 1,000 On September 16, 2021, the conversion rate for each share of Series E Preferred Stock was amended to equal (i)(a) 56.60% multiplied by, (b) the Fully-Diluted shares as of the Approval Date (each as defined in the Series E Certificate), divided by (ii) the total number of shares of Series E Preferred Stock, (iii) rounded to the nearest thousandth. The total number of Fully-Diluted Shares is set as of, and cannot change after the Approval Date. Based on the current fully-diluted shares outstanding, this equated to 2,243,888,889 shares of Common Stock. Fully-Diluted means the aggregate of (A) the total number of shares of Common Stock outstanding as of such date, (B) the number of shares of Common Stock (including all such Common Stock equivalents) into which all Convertible Securities outstanding as of such date could be converted or exercised, and (C) the number of shares of Common Stock (including all such Common Stock equivalents) issuable upon exercise of all options outstanding as of such date of exercise, divided by 0.4340. On February 16, 2021, we issued 1,000 4,225,062 On September 16, 2021, the holders of our Series E Preferred Stock entered into an exchange agreement with us whereby on October 11, 2021, the 1,000 1,152,500 1,091,388,889 4,225,062 1,000 no Series E-1 Preferred Stock There are 1,152,500 0.87 1,152,500 Each share of Series E-1 Preferred Stock may be converted into 1,000 Series F Preferred Stock There are 1,000 1.00 On February 17, 2021, we issued to the Investors 1,000 192,073,017 864,000 0.0045 On September 16, 2021, the conversion rate for each share of Series F Preferred Stock was amended to equal (i)(a) 4.84% multiplied by, (b) the Fully-Diluted shares as of the Approval Date (each as defined in the Series F Certificate), divided by (ii) the total number of shares of Series F Preferred Stock, (iii) rounded to the nearest thousandths place. The total number of Fully-Diluted Shares is set as of, and can not change after the Approval Date. Based on the full-diluted shares outstanding, this equated to 192,073,017 shares of Common Stock on the Approval Date. Fully-Diluted means the aggregate of (A) the total number of shares of Common Stock outstanding as of such date, (B) the number of shares of Common Stock (including all such Common Stock equivalents) into which all Convertible Securities outstanding as of such date could be converted or exercised, and (C) the number of shares of Common Stock (including all such Common Stock equivalents) issuable upon exercise of all options outstanding as of such date of exercise, divided by 0.9516. On October 11, 2021, the 1,000 192,073,017 As at March 31, 2023 and December 31, 2022, no Series G Preferred Stock On August 20, 2021, the certificate of designation for the Series G Preferred Stock was amended. There are now 4,600 4.99 9.9 1,000 On September 16, 2021, the conversion rate for each share of Series G Preferred Stock was amended to equal (i)(a) 6.45% multiplied by, (b) the Fully-Diluted shares as of the Approval Date (each as defined in the Series G Certificate, divided by (ii) the total number of shares of Series G Preferred Stock, (iii) rounded to the nearest thousandths place. The total number of Fully-Diluted Shares is set as of, and does not change after the Approval Date. Based on the current fully-diluted shares outstanding, this equated to 255,555,556 shares of common stock on the Approval Date. Fully-Diluted means the aggregate of (A) the total number of shares of Common Stock outstanding as of such date, (B) the number of shares of Common Stock (including all such Common Stock equivalents) into which all Convertible Securities outstanding as of such date could be converted or exercised, and (C) the number of shares of Common Stock (including all such Common Stock equivalents) issuable upon exercise of all options outstanding as of such date of exercise, divided by 0.9355. We received $ 4,600,000 4,600 1,000 4,600 255,555,556 no Series H Preferred Stock On November 5, 2021, we designated 39,895 1.00 Shares of Series H Preferred Stock have no voting rights and are senior in dividend rights and liquidation preference to our Common Stock and all other Common Stock Equivalents. Each share of Series H Preferred Stock may be converted into 1,000 shares of Common Stock, subject to a maximum ownership limit of 9.99%. On November 11, 2021, pursuant to an exchange agreement that we entered into with the Investors, 39,895,000 39,895 39,895,000 39,895 3,989,500 39,895

Shareholders_ Equity

Shareholders’ Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Shareholders’ Equity	Note 9 Shareholders’ Equity Preferred Stock As of March 31, 2023 and December 31, 2022, we are authorized to issue 50,000,000 48,617,400 Series B Preferred Stock There are 100 Holders of Series B Preferred Stock have the right to vote on all shareholder matters equal to 51% of the total voting power of each class of stock outstanding. Holders of shares of Series B Preferred are entitled to such 51% voting rights regardless of the number of voting shares issued by the company at any time. On July 17, 2020, 100 Although the Series B Preferred Stock is entitled to 51% voting rights as described above, the stock has no dividend rate nor conversion feature. On February 17, 2021, the 100 At March 31, 2023 and December 31, 2022, there were 100 Common Stock As of March 31, 2023 and December 31, 2022 there were 1,603,095,243 Warrants On January 10, 2023, we issued two unsecured convertible subordinate notes totaling $ 220,000 40,000,000 0.02 The Warrants issued were loan incentives. The value was allocated to the warrants based on its fair value on the date of the grant, as determined using the Black-Scholes option pricing model. For the three months ended March 31, 2023, a summary of our warrant activity is as follows: Number of Warrants Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Weighted- Average Grant- Date Fair Value Aggregate Intrinsic Value Outstanding and exercisable at January 1, 2023 246,173,016 $ 0.021 3.69 $ 399,783 $ 4,431,114 - Issued 40,000,000 $ 0.020 6.79 — $ — Exercised — — — — — Expired — — — — — Outstanding and exercisable at March 31, 2023 286,173,016 $ 0.021 3.91 $ 343,904 $ 4,431,114

Discontinued Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Note 10 Discontinued Operations In the fourth quarter of 2022, management at that time determined that Sovryn’s television broadcast business was not an efficient use of our resources to develop and launch BCTV, our core business, and management sought to exit Sovryn’s business and pay down the Company’s senior debt associated with acquiring Sovryn’s assets and creating its business. As a result, Sovryn is recognized as a discontinued operation in the accompanying condensed consolidated financial statements. Effective February 1, 2023, we assigned 100% ownership of Sovryn to the Investors. The previous year’s assets, liabilities and expenses have been similarly classified for comparative purposes. The following is a summary of Sovryn for the three months ended March 31, 2023 and 2022: Schedule of Previous Year Assets Liabilities and Expenses March 31, March 31, 2023 2022 Assets Current assets $ — $ 342,264 Property, equipment and right-of-use assets — 2,823,224 Intangible assets — 12,027,769 Total Assets — 15,193,257 Liabilities Accounts payable and accrued liabilities — 620,306 Lease liability obligations — 1,468,233 Total Liabilities — 2,088,539 Revenues 163,473 474,999 Selling, general and administrative (9,886 ) (134,589 ) Television operation — (87,632 ) Amortization — (80,494 ) Professional fees — (201,336 ) Interest expense — (2,904 ) Gain (loss) on asset disposals 6,695,083 (52,668 ) Impairment loss — — Gain (loss) from discontinued operations $ (6,521,724 ) $ (84,624 )

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 11 Income Taxes Income tax recovery differs from that which would be expected from applying the effective tax rates to the net income (loss) as follows: Schedule of Income Tax Expense March 31, 2023 March 31, 2022 Net loss for the three-month period $ (10,768,418 ) $ (2,536,688 ) Statutory and effective tax rates 21.0 % 21.0 % Income taxes expenses (recovery) at the effective rate $ (2, 261,368 ) $ (532,704 ) Effect of change in tax rates — — Permanent differences — — Valuation allowance 2,261,368 532,704 Income tax expense and income tax liability $ — $ — As of March 31, 2023 and December 31, 2022, the tax effect of the temporary timing differences that give rise to significant components of deferred income tax asset are noted below. A valuation allowance has been recorded, as management believes it is more likely than not that the deferred income tax asset will not be realized. Schedule of Deferred Income Tax Asset March 31, 2023 December 31, 2022 Tax loss carried forward $ — $ — Deferred tax assets $ 5,020,728 $ 2,759,360 Valuation allowance (5,020,728 ) (2,759,360 ) Deferred taxes recognized $ — $ — Tax losses of approximately $ 30

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 12 Subsequent Events On September 21, 2023, the Agent for the Investors delivered a notice to us that the Agent has exercised the Investors’ rights to vote the Pledged Interests (as defined in such notice) and to exercise the Investors’ rights, powers and privileges, to pass certain resolutions and to amend our bylaws then in effect to, among other things, (i) remove the board of directors of the Company (the “Board of Directors”) and all officers of the Company, and (ii) reduce the number of the Board of Directors from three to one director. As a result of the Agent delivering such notice and exercising its rights to vote the Pledged Interests, a change of control of the Company occurred (the “Change of Control”). On the two-year anniversary of the October 11, 2021 issuance of the Series E-1 shares, the shares were to be automatically converted into 1,152,500,000 On November 6, 2023, the shareholders of the Company removed Philip Falcone and Warren Zenna as our directors and appointed Thomas Amon as the sole member of our board of directors. Mr. Amon removed all Company officers and appointed himself as the Company’s President, Secretary, Treasurer, Chief Executive Officer, Chief Financial Officer, Principal Executive Officer and Principal Accounting Officer. On November 10, 2023, Philip Falcone, individually and on behalf of the Company and other named defendants, filed a Confession of Judgment affirming that a promissory note (the “Z4 Note”) had been issued by the Company, dated December 28, 2021, by Z4 MGMT LLC (“Z4”), which was guaranteed by each of FFO1 2021 Irrevocable Trust and FFO2 2021 Irrevocable Trust. The Z4 Note was initially payable on February 15, 2022, and had an original principal balance of $500,000 with an interest rate of 12% per annum. The Z4 Note’s expiration date was extended to July 5, 2022, then further extended to March 31, 2023, and as of October 1, 2023, the revised principal balance, along with interest accrued, totaled $581,304. On such date, Z4 filed an Affidavit of Default affirming that the Z4 Note was in default and requesting a judgment in the amount of $581,304 against the Company, FFO1 2021 Irrevocable Trust, FFO2 2021 Irrevocable Trust, and Mr. Falcone personally, in favor of Z4. On February 18, 2024, Agile Capital Funding LLC (“Agile”) filed a Confession of Judgment executed by Philip Falcone with the Supreme Court of the State of New York County of New York that affirmed that the Company owes Agile for funds received on January 30, 2023, less funds the Company subsequently repaid, and for accrued interest and collection fees, which Agile determined to be $ 190,444 Presently, we are default on all of our outstanding promissory and convertible notes payable (See Notes 4, 5 and 6), which have $ 3.5

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Use of estimates	Use of estimates The preparation of the condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.
Consolidation	Consolidation The accompanying condensed consolidated financial statements include the accounts of our current and former wholly owned subsidiaries, Blockchain.tv, Inc. and SovRryn Holdings Inc. (“Sovryn”). Sovryn is consolidated up until January 31, 2023 and recognized as a discontinued operation. All the intercompany balances and transactions have been eliminated in the consolidation.
Interim Reporting	Interim Reporting While the information presented in the accompanying interim three-month financial statements is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. These interim financial statements follow the same accounting policies and methods of their application as the Company’s December 31, 2022 annual financial statements. All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Company’s December 31, 2022 annual financial statements. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that can be expected for the year ended December 31, 2023.
Segment reporting	Segment reporting Our chief operating decision maker is our chief executive officer, who reviews information on an aggregated basis.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.
Revenue recognition	Revenue recognition We adopted the ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). We recognize revenue when we transfer promised services to the customer. The performance obligation is the monthly services rendered. We have one main revenue source which is leasing of television station channels. Accordingly, we recognize revenue when services are provided as time passes the customers have access to utilize the channel. These revenues are billed in advance, arrears and/or are prepaid. The performance obligation is the monthly services rendered. At March 31, 2023, we have one main revenue source, which is the leasing of television channels. Where there is a leasing contract for channels, we bill monthly for our services as rendered. Where there is no contract, the revenue is recognized as provided. We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues: ● identify the contract with a customer; ● identify the performance obligations in the contract; ● determine the transaction price; ● allocate the transaction price to performance obligations in the contract; and ● recognize revenue as the performance obligation is satisfied. Advances from client deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from client deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets In accordance with the provisions of ASC Topic 360, “Impairment or Disposal of Long-Lived Assets ”
Financial instruments	Financial instruments Our financial instruments consist principally of accounts payable, accrued liabilities and notes payable. The carrying amounts of such financial instruments in the accompanying financial statements approximate their fair values due to their relatively short-term nature or the underlying terms are consistent with market terms. It is the management’s opinion that we are not exposed to any significant currency or credit risks arising from these financial instruments.
Fair value measurements	Fair value measurements We follow the guidelines in ASC Topic 820 “Fair Value Measurements and Disclosures”. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. All financial instruments approximate their fair value. Level 1 — Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets. Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3—inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models.
Convertible Notes with Fixed Rate Conversion Options	Convertible Notes with Fixed Rate Conversion Options We may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. We record the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the note date with a charge to interest expense in accordance with ASC 480–- “Distinguishing Liabilities from Equity”.
Derivative Liabilities	Derivative Liabilities We have certain financial instruments that are derivatives or contain embedded derivatives. We evaluate all of our financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 810-10-05-4 and 815-40. This accounting treatment requires that the carrying amount of any derivatives be recorded at fair value at issuance and marked-to-market at each balance sheet date. In the event that the fair value is recorded as a liability, as is the case with us, the change in the fair value during the period is recorded as either other income or expense. Upon conversion, exercise or repayment, the respective derivative liability is marked to fair value at the conversion, repayment or exercise date and then the related fair value amount is reclassified to other income or expense as part of gain or loss on extinguishment.
Schedule of Potentially Dilutive Securities	Loss per share Net Loss Per Share Basic loss per share is calculated by dividing the loss attributable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in our earnings (loss). Diluted loss per share is computed by dividing the loss available to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless such dilutive potential shares would result in anti-dilution. As of March 31, 2023 and 2022, no options were outstanding and 286,173,016 203,673,016 22,154,828 19,383,713 1,187,237,384 951,018,661 318,056,580 155,000,000 1,152,500,000 39,895,000 3,138,861,880 2,501,586,677 the number of shares converted into either 4.99% or 9.99% of the then outstanding shares. Schedule of Potentially Dilutive Securities March 31, 2023 March 31, 2022 Warrants 286,173,016 203,673,016 Convertible Preferred Stock 1,665,451,580 1,346,895,000 Convertible debt 1,187,237,384 951,018,661 Total 3,136,861,880 2,501,586,677
Related Party Transactions	Related Party Transactions We follow FASB ASC subtopic 850-10, “Related Party Transactions”, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: (a) our affiliates; (b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; (d) our principal owners; ©) our management; (f) other parties with which we may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Material related party transactions are required to be disclosed in the condensed consolidated financial statements, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Discontinued operations	Discontinued operations Discontinued operations are components of an entity that either have been disposed or abandoned or is classified as held for sale. Additionally, in order to qualify as a discontinued operation, the disposal or abandonment must represent a strategic shift that has or will have a major effect on an entity’s operations and financial results.
Income taxes	Income taxes We follow the guideline under ASC Topic 740 Income Taxes. “Accounting for Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Due to the uncertainty regarding our future profitability, the future tax benefits of its losses have been fully reserved.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements We adopt new pronouncements relating to generally accepted accounting principles applicable to us as they are issued, which may be in advance of their effective date. We do not believe that any recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying condensed consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Schedule of Potentially Dilutive Securities	Schedule of Potentially Dilutive Securities March 31, 2023 March 31, 2022 Warrants 286,173,016 203,673,016 Convertible Preferred Stock 1,665,451,580 1,346,895,000 Convertible debt 1,187,237,384 951,018,661 Total 3,136,861,880 2,501,586,677

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
Accounts payable and accrued liabilities are summarized below:	Accounts payable and accrued liabilities are summarized below: March 31, 2023 December 31, 2022 Accounts payable $ 385,797 $ 371,987 Accrued expenses 293,210 174,078 Accrued interest 281,988 195,334 Total $ 960,994 $ 741,399

Derivative Liability (Tables)

Derivative Liability (Tables)	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Liability	For the three months ended March 31, 2023, our derivative liability was as follows: Schedule of Derivative Liability March 31, 2023 Balance at January 1, 2023 $ 4,429,329 Liability for Warrants issued — Balance at March 31, 2023 $ 4,429,329

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2023
Convertible Notes Payable
Schedule of Convertible Notes Payable	Our convertible notes payable, all of which are current liabilities, are as follows as of: Schedule of Convertible Notes Payable March 31, December 31, Series 1 (a) 1,050,000 1,050,000 Series 2 (b) 470,000 250,000 Series 3 (c) 208,000 208,000 Series 4 (d) 220,000 550,000 Series 5 (e) 542,500 192,500 Series 6 (f) 55,000 55,000 Principal outstanding 2,545,500 2,305,500 Less discount 262,203 426,094 Principal outstanding, net $ 2,283,297 $ 1,879,406 (a) Series 1: We issued a total of $ 1,050,000 6 December 31, 2022 0.021 (b) Series 2: On January 6, 2022, we issued to one of our shareholders a $ 250,000 12 April 6, 2022 6,250,000 0.021 112,500 0.018 On January 14, 2022, we issued to one of our shareholders a $ 25,000 12 600,000 0.021 10,800 0.018 On February 17, 2022, we issued a $ 50,000 12 April 6, 2022 1,250,000 0.021 22,500 0.018 (c) Series 3: On February 15, 2022, we issued two $ 137,500 11.25 February 23, 2023 15,000 2,500,000 0.10 90,000 0.018 0.02 67,000 13,004 (d) Series 4: On May 5, 2022, we issued a shareholder a convertible subordinate note totaling $ 110,000 12 May 5, 2023 0.02 5,000,000 0.02 On June 24, 2022, we issued a convertible subordinate note totaling $ 110,000 12 May 5, 2023 0.02 5,000,000 0.02 (e) Series 5: On May 5, 2022, we issued an $ 82,500 7,500 May 5, 2023 12 3,750,000 0.02 67,500 0.018 82,500 On May 5, 2022, we issued a $ 110,000 10,000 May 5, 2023 12 5,000,000 0.02 90,000 0.018 110,000 On October 14, 2022, we issued a $ 110,000 10,000 October 14, 2023 12 5,000,000 0.02 90,000 0.018 110,000 On December 2, 2022, we issued a $ 220,000 20,000 October 14, 2023 12 10,000,000 0.02 180,000 0.018 220,000 (f) Series 6: On September 16, 2022, we issued a $ 55,000 5,000 September 16, 2023 12 0.001 55,000

Senior Secured Notes (Tables)

Senior Secured Notes (Tables)	3 Months Ended
	Mar. 31, 2023
Senior Secured Notes
Schedule of senior secured Note	Schedule of senior secured Note March 31, December 31, Principal $ 16,500,000 $ 16,500,000 Less discount 1,486,551 1,900,760 Principal, net of discount $ 15,013,449 $ 14,599,240

Shareholders_ Equity (Tables)

Shareholders’ Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
For the three months ended March 31, 2023, a summary of our warrant activity is as follows:	For the three months ended March 31, 2023, a summary of our warrant activity is as follows: Number of Warrants Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Weighted- Average Grant- Date Fair Value Aggregate Intrinsic Value Outstanding and exercisable at January 1, 2023 246,173,016 $ 0.021 3.69 $ 399,783 $ 4,431,114 - Issued 40,000,000 $ 0.020 6.79 — $ — Exercised — — — — — Expired — — — — — Outstanding and exercisable at March 31, 2023 286,173,016 $ 0.021 3.91 $ 343,904 $ 4,431,114

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Previous Year Assets Liabilities and Expenses	Schedule of Previous Year Assets Liabilities and Expenses March 31, March 31, 2023 2022 Assets Current assets $ — $ 342,264 Property, equipment and right-of-use assets — 2,823,224 Intangible assets — 12,027,769 Total Assets — 15,193,257 Liabilities Accounts payable and accrued liabilities — 620,306 Lease liability obligations — 1,468,233 Total Liabilities — 2,088,539 Revenues 163,473 474,999 Selling, general and administrative (9,886 ) (134,589 ) Television operation — (87,632 ) Amortization — (80,494 ) Professional fees — (201,336 ) Interest expense — (2,904 ) Gain (loss) on asset disposals 6,695,083 (52,668 ) Impairment loss — — Gain (loss) from discontinued operations $ (6,521,724 ) $ (84,624 )

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Income Tax Expense	Income tax recovery differs from that which would be expected from applying the effective tax rates to the net income (loss) as follows: Schedule of Income Tax Expense March 31, 2023 March 31, 2022 Net loss for the three-month period $ (10,768,418 ) $ (2,536,688 ) Statutory and effective tax rates 21.0 % 21.0 % Income taxes expenses (recovery) at the effective rate $ (2, 261,368 ) $ (532,704 ) Effect of change in tax rates — — Permanent differences — — Valuation allowance 2,261,368 532,704 Income tax expense and income tax liability $ — $ —
Schedule of Deferred Income Tax Asset	As of March 31, 2023 and December 31, 2022, the tax effect of the temporary timing differences that give rise to significant components of deferred income tax asset are noted below. A valuation allowance has been recorded, as management believes it is more likely than not that the deferred income tax asset will not be realized. Schedule of Deferred Income Tax Asset March 31, 2023 December 31, 2022 Tax loss carried forward $ — $ — Deferred tax assets $ 5,020,728 $ 2,759,360 Valuation allowance (5,020,728 ) (2,759,360 ) Deferred taxes recognized $ — $ —

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net income loss	$ (10,768,418)	$ (2,536,688)	$ 13,139,810
Working capital deficit			13,860,314
Accumulated deficit	$ 39,655,249		$ 28,886,831

Schedule of Potentially Dilutiv

Schedule of Potentially Dilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	3,136,861,880	2,501,586,677
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	286,173,016	203,673,016
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,665,451,580	1,346,895,000
Convertible Debt [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,187,237,384	951,018,661

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion of shares, stock converted	3,136,861,880	2,501,586,677
Interest on convertible debt, net of tax	$ 22,154,828	$ 19,383,713
Debt conversion into stock	1,187,237,384	951,018,661
Common stock, conversion basis	the number of shares converted into either 4.99% or 9.99% of the then outstanding shares.
Series A Preferred Stock [Member] | Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion of shares, stock converted	318,056,580
Series D Preferred Stock [Member] | Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion of shares, stock converted	155,000,000
Series E-1 Preferred Stock [Member] | Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion of shares, stock converted	1,152,500,000
Series H Preferred Stock [Member] | Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion of shares, stock converted	39,895,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion of shares, stock converted	286,173,016	203,673,016

Accounts payable and accrued _3

Accounts payable and accrued liabilities are summarized below: (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 385,797	$ 371,987
Accrued expenses	293,210	174,078
Accrued interest	281,988	195,334
Total	$ 960,994	$ 741,399

Schedule of Derivative Liabilit

Schedule of Derivative Liability (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Balance at January 1, 2023	$ 4,429,329
Liability for Warrants issued
Balance at March 31, 2023	$ 4,429,329

Derivative Liability (Details N

Derivative Liability (Details Narrative)	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative liability description	As a better representation of value, management used a share price of $0.018 per share to determine the derivative liability from warrants issued through December 31, 2022, which was the per share price used in connection with the issuance of 255,555,556 shares of Common Stock issued upon conversion of the Series G Preferred Stock on November 2, 2021.
Warrants liability | $	$ 40,000,000
Common stock per share | $ / shares	$ 0.02

Promissory Notes (Details Narra

Promissory Notes (Details Narrative) - USD ($)	Apr. 27, 2022	Jan. 14, 2022	Dec. 28, 2021	Mar. 31, 2023	Jun. 26, 2022
Share issued price per share				$ 0.02
Common Stock [Member]
Share issued price per share	$ 0.018
Warrants and rights outstanding	$ 45,000
Unsecured Debt [Member]
Sale of notes payable		$ 150,000
Debt instrument, maturity date		Apr. 05, 2022
Debt fees payable		$ 15,000
Unsecured Debt One [Member]
Sale of notes payable		$ 150,000
Debt instrument, maturity date		Apr. 05, 2022
Debt fees payable		$ 15,000
January 14, 2022 [Member] | Unsecured Debt [Member]
Notes payable, outstanding				$ 120,000
Promissory Note [Member] | December 28, 2022 [Member]
Notes payable, outstanding				500,000
Unsecured Notes Payable One [Member]
Sale of notes payable	$ 125,000
Debt instrument, maturity date	Dec. 31, 2022
Debt original discount	$ 12,500
Unsecured Notes Payable One [Member] | January 14, 2022 [Member]
Notes payable, outstanding				135,000
Unsecured Notes Payable One [Member] | April 27, 2022 [Member]
Notes payable, outstanding				$ 125,000
Unsecured Notes PayableTwo [Member] | Common Stock [Member]
Purchase of warrants	2,500,000
Warrant exercise price	$ 0.025
Z4 Management LLC [Member]
Sale of notes payable			$ 500,000
Debt instrument interest rate stated percentage			12%
Debt instrument, maturity date			Mar. 31, 2023
Warrants shares issued			500,000
Warrant maturity date			Dec. 31, 2023
Share issued price per share			$ 0.018		$ 0.025
Warrants and rights outstanding			$ 9,000

Schedule of Convertible Notes P

Schedule of Convertible Notes Payable (Details) - USD ($)			12 Months Ended
		Apr. 27, 2022	Dec. 31, 2022	Mar. 31, 2023	Oct. 25, 2022
Principal outstanding				$ 2,545,500
Less discount				262,203
Principal outstanding, net				$ 2,283,297
Fixed price per share				$ 0.02
Convertible notes					$ 67,000
Principal and interest					$ 13,004
Unsecured Notes Payable One [Member]
Maturity date		Dec. 31, 2022
Series 1 [Member]
Principal outstanding	[1]			$ 1,050,000
Series 1 [Member] | Unsecured Notes Payable One [Member]
Principal outstanding			$ 1,050,000
Interest rate, percentage			6%
Maturity date			Dec. 31, 2022
Fixed price per share			$ 0.021
Series 2 [Member]
Principal outstanding	[2]			470,000
Series 3 [Member]
Principal outstanding	[3]			208,000
Series 4 [Member]
Principal outstanding	[4]			220,000
Series 5 [Member]
Principal outstanding	[5]			542,500
Series Six [Member]
Principal outstanding	[6]			$ 55,000
[1]Series 1:[2]Series 2:[3]Series 3:[4]Series 4:[5]Series 5:[6]Series 6:

Schedule of Convertible Notes_2

Schedule of Convertible Notes payable (Details) (Parenthetical) - USD ($)													1 Months Ended	3 Months Ended
	Dec. 02, 2022	Oct. 14, 2022	Oct. 14, 2022	Sep. 16, 2022	Sep. 16, 2022	Jun. 24, 2022	May 05, 2022	May 05, 2022	Feb. 17, 2022	Jan. 14, 2022	Jan. 06, 2022	Feb. 17, 2021	Feb. 15, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Apr. 27, 2022	Oct. 11, 2021	Sep. 24, 2021
Common stock per share														$ 0.02
Share issued price per share														$ 0.001		$ 0.001
Adjustment of warrants															$ 9,000
Series F Preferred Stock [Member]
Share issued price per share												$ 0.0045
Securities Purchase Agreement [Member] | Investors [Member]
Interest rate, percentage												11%
Class of warrant or right number of securities called by warrants or right												192,073,017
Securities Purchase Agreement [Member] | Investors [Member] | Series F Preferred Stock [Member]
Class of warrant or right number of securities called by warrants or right												1,000						192,073,017	192,073,017
Adjustment of warrants												$ 864,000
Common Stock [Member]
Warrants and rights outstanding																	$ 45,000
Common stock per share																	$ 0.018
Share issued price per share													$ 0.02
Common Stock [Member] | Securities Purchase Agreement [Member] | Investors [Member]
Class of warrant or right number of securities called by warrants or right												192,073,017
Common stock per share												$ 0.0045							$ 0.02
Series 4 [Member] | Common Stock [Member]
Common stock per share						$ 0.02	$ 0.02	$ 0.02
Unsecured Notes PayableTwo [Member] | Common Stock [Member]
Class of warrant or right number of securities called by warrants or right																	2,500,000
Warrant exercise price																	$ 0.025
Unsecured Notes PayableTwo [Member] | Series 2 [Member]
Notes payable									$ 50,000	$ 25,000	$ 250,000
Interest rate, percentage									12%	12%	12%
Maturity date									Apr. 06, 2022		Apr. 06, 2022
Warrant exercise price									$ 0.021	$ 0.021
Unsecured Notes PayableTwo [Member] | Series 2 [Member] | Common Stock [Member]
Class of warrant or right number of securities called by warrants or right									1,250,000	600,000	6,250,000
Warrant exercise price											$ 0.021
Warrants and rights outstanding									$ 22,500	$ 10,800	$ 112,500
Common stock per share									$ 0.018	$ 0.018	$ 0.018
Unsecured Notes Payable Three [Member]
Warrants and rights outstanding													$ 90,000
Unsecured Notes Payable Three [Member] | Common Stock [Member]
Share issued price per share													$ 0.018
Unsecured Notes Payable Three [Member] | Series 3 [Member]
Notes payable													$ 137,500
Interest rate, percentage													11.25%
Maturity date													Feb. 23, 2023
Issue discount													$ 15,000
Unsecured Notes Payable Three [Member] | Series 3 [Member] | Common Stock [Member]
Class of warrant or right number of securities called by warrants or right													2,500,000
Warrant exercise price													$ 0.10
Unsecured Notes Payable Four [Member] | Series 4 [Member]
Notes payable						$ 110,000	$ 110,000
Interest rate, percentage						12%	12%	12%
Maturity date						May 05, 2023	May 05, 2023
Unsecured Notes Payable Four [Member] | Series 4 [Member] | Common Stock [Member]
Class of warrant or right number of securities called by warrants or right						5,000,000	5,000,000	5,000,000
Debt instrument convertible						$ 0.02	$ 0.02	$ 0.02
Unsecured Notes Payable Five [Member] | Series 5 [Member]
Notes payable								$ 82,500
Interest rate, percentage							12%	12%
Maturity date							May 05, 2023
Class of warrant or right number of securities called by warrants or right							3,750,000	3,750,000
Warrant exercise price							$ 0.02	$ 0.02
Issue discount							$ 7,500	$ 7,500
Notes payable							82,500	82,500
Unsecured Notes Payable Five [Member] | Series 5 [Member] | Common Stock [Member]
Warrants and rights outstanding							$ 67,500	$ 67,500
Share issued price per share							$ 0.018	$ 0.018
Unsecured Notes Payable Six [Member]
Notes payable																$ 55,000
Unsecured Notes Payable Six [Member] | Series 5 [Member]
Notes payable	$ 220,000	$ 110,000						$ 110,000
Interest rate, percentage		12%	12%				12%	12%
Maturity date			Oct. 14, 2023				May 05, 2023
Class of warrant or right number of securities called by warrants or right	10,000,000	5,000,000	5,000,000				5,000,000	5,000,000
Warrant exercise price		$ 0.02	$ 0.02				$ 0.02	$ 0.02
Warrants and rights outstanding	$ 180,000	$ 90,000	$ 90,000
Issue discount	$ 20,000	$ 10,000	$ 10,000				$ 10,000	$ 10,000
Share issued price per share	$ 0.018	$ 0.018	$ 0.018
Notes payable		$ 110,000	$ 110,000											$ 220,000		$ 220,000
Unsecured Notes Payable Six [Member] | Series 5 [Member] | Common Stock [Member]
Warrants and rights outstanding							$ 90,000	$ 90,000
Share issued price per share							$ 0.018	$ 0.018
Unsecured Notes Payable Six [Member] | Series Six [Member]
Notes payable					$ 55,000
Interest rate, percentage				12%	12%
Maturity date				Sep. 16, 2023
Issue discount				$ 5,000	$ 5,000
Unsecured Notes Payable Six [Member] | Series Six [Member] | Common Stock [Member]
Share issued price per share				$ 0.001	$ 0.001

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	Feb. 17, 2022	Oct. 11, 2021	Feb. 17, 2021	Mar. 31, 2023	Dec. 31, 2022	Apr. 27, 2022	Sep. 24, 2021
Common stock per share				$ 0.02
Securities Purchase Agreement [Member] | Investors [Member]
Debt instrument interest rate stated percentage			11%
Class of warrant or right number of securities called by warrants or right			192,073,017
Debt conversion description			The Notes have a term of thirty-six months and mature on February 17, 2024, unless earlier converted. The Notes accrue interest at a rate of 11% per annum, subject to increase to 20% per annum upon default. Interest is payable in cash on a quarterly basis beginning on March 31, 2021. Notwithstanding the above, at our election, any interest payable on an applicable payment date may be paid in registered shares of our Common Stock in an amount equal (A) the amount of the interest payment due on such date, divided by (B) an amount equal to 80% of the average volume-weighted average price of our Common Stock for the five (5) days immediately preceding the date of conversion.
Interest payable current and noncurrent				$ 3,619,000	$ 3,300,000
Securities Purchase Agreement [Member] | Investors [Member] | Maximum [Member]
Common stock per share							$ 0.025
Securities Purchase Agreement [Member] | Investors [Member] | Minimum [Member]
Common stock per share							$ 0.020
Securities Purchase Agreement [Member] | Investors [Member] | Series F Preferred Stock [Member]
Class of warrant or right number of securities called by warrants or right		192,073,017	1,000				192,073,017
Voting rights description		The Series F Preferred Stock has no voting rights and converts into 4.9% of our issued and outstanding shares of our Common Stock on a fully diluted basis upon the date on which stockholder approval for such issuance is obtained.
Common Stock [Member]
Warrants and rights outstanding						$ 45,000
Common stock per share						$ 0.018
Common Stock [Member] | Securities Purchase Agreement [Member] | Investors [Member]
Class of warrant or right number of securities called by warrants or right			192,073,017
Common stock per share			$ 0.0045				$ 0.02
Unsecured Notes Payable [Member]
Proceeds from unsecured note payable	$ 50,000
Debt instrument interest rate stated percentage	12%
Maturity date	Apr. 06, 2022
Warrants and rights outstanding	$ 22,500
Unsecured Notes Payable [Member] | Common Stock [Member]
Class of warrant or right number of securities called by warrants or right	1,250,000
Warrant exercise price	$ 0.021
Common stock per share	$ 0.018

Schedule of senior secured Note

Schedule of senior secured Note (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Senior Secured Notes
Principal	$ 16,500,000	$ 16,500,000
Less discount	1,486,551	1,900,760
Principal, net of discount	$ 15,013,449	$ 14,599,240

Senior Secured Notes (Details N

Senior Secured Notes (Details Narrative) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Senior Secured Notes
Accrued interest payable	$ 3,753,750	$ 3,300,000

Related Party (Details Narrativ

Related Party (Details Narrative) - Chief Executive Officer [Member] - Philip Falcone [Member] - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jan. 31, 2022
Related Party Transaction [Line Items]
Monthly renmuneration			$ 35,000
Consulting fees	$ 35,000	$ 40,000
Payment for bonus	$ 128,473	$ 233,140

Mezzanine Equity (Details Narra

Mezzanine Equity (Details Narrative) - USD ($)										3 Months Ended
	Nov. 11, 2021	Nov. 05, 2021	Nov. 02, 2021	Oct. 11, 2021	Sep. 16, 2021	Aug. 20, 2021	Feb. 17, 2021	Feb. 16, 2021	Jul. 17, 2020	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Feb. 15, 2022
Debt instrument converted shares										1,187,237,384	951,018,661
Convertible note spayable										$ 2,545,500
Common stock, par value										$ 0.001		$ 0.001
Common Stock [Member]
Conversion of convertible shares			255,555,556	192,073,017			192,073,017	75,000,000
Common stock, par value													$ 0.02
Common Stock [Member] | Exchange Agreement [Member]
Conversion of shares	39,895,000
Number of shares issued					1,091,388,889
Series A Preferred Stock [Member]
Temporary equity, shares authorized										100,000
Debt instrument conversion percentage										9.99%
Debt instrument converted shares										3,420
Diluted shares										360,000,000
Number of shares issued									92,999
Shares issued for license									$ 343,094
Preferred shares, description									the acquisition cost derived using the $0.04 market price on that date of $0.04 multiplied by 95% of the number of our issued and outstanding shares at the time (18,057,565) and multiplied by 50% of that value.
Series C Preferred Stock [Member]
Debt instrument conversion percentage										9.99%
Temporary equity, shares authorized										10,000
Voting rights, description										Holders of Series C Preferred Stock are entitled to receive, when and as declared, dividends equal to 2% per annum on the stated value, payable in additional shares of Series C Preferred Stock. So long as any shares of Series C Preferred Stock remain outstanding, without the consent of the holders of 80% of the shares of Series C Preferred Stock then outstanding, we may not redeem, repurchase or otherwise acquire directly or indirectly any securities deemed junior to such Series C Preferred Stock (“Junior Securities”) nor may we directly or indirectly pay or declare or make any distribution upon, nor may any distribution be made in respect of, any Junior Securities
Series C Preferred Stock [Member] | Common Stock [Member]
Debt instrument converted shares										100
Series D Preferred Stock [Member]
Temporary equity, shares authorized										230,000
Temporary equity stated value per share										$ 3.32
Notes payable								$ 1,028,000
Convertible note spayable								$ 230,000
Conversion of convertible shares								75,000
Preferred stock, shares outstanding								155,000
Series D Preferred Stock [Member] | Minimum [Member]
Debt instrument conversion percentage										4.99%
Series D Preferred Stock [Member] | Maximum [Member]
Debt instrument conversion percentage										9.99%
Series D Preferred Stock [Member] | Common Stock [Member]
Debt instrument converted shares										1,000
Series E Preferred Stock [Member]
Temporary equity, shares authorized										1,000
Temporary equity stated value per share										$ 1,000
Temporary equity description					the conversion rate for each share of Series E Preferred Stock was amended to equal (i)(a) 56.60% multiplied by, (b) the Fully-Diluted shares as of the Approval Date (each as defined in the Series E Certificate), divided by (ii) the total number of shares of Series E Preferred Stock, (iii) rounded to the nearest thousandth. The total number of Fully-Diluted Shares is set as of, and cannot change after the Approval Date. Based on the current fully-diluted shares outstanding, this equated to 2,243,888,889 shares of Common Stock. Fully-Diluted means the aggregate of (A) the total number of shares of Common Stock outstanding as of such date, (B) the number of shares of Common Stock (including all such Common Stock equivalents) into which all Convertible Securities outstanding as of such date could be converted or exercised, and (C) the number of shares of Common Stock (including all such Common Stock equivalents) issuable upon exercise of all options outstanding as of such date of exercise, divided by 0.4340.
Temporary equity, shares outstanding										0
Series E Preferred Stock [Member] | Exchange Agreement [Member]
Conversion of convertible shares					1,000
Conversion of shares					1,000
Conversion of convertible securities					$ 4,225,062
Series E Preferred Stock [Member] | Sovryn Holdings, Inc [Member]
Number of shares issued on acquisition, shares								1,000
Number of shares issued on acquisition								$ 4,225,062
Series E-1 Preferred Stock [Member]
Temporary equity, shares authorized										1,152,500		1,152,500
Temporary equity, shares outstanding										1,152,500		1,152,500
Temporary equity, stated value										$ 0.001		$ 0.001
Temporary equity, stated value										$ 0.87		$ 0.87
Series E-1 Preferred Stock [Member] | Exchange Agreement [Member]
Number of shares issued					1,152,500
Series E One Convertible Preferred Stock [Member]
Temporary equity, shares authorized										1,152,500
Temporary equity, shares outstanding										1,152,500
Temporary equity, stated value										$ 0.87
Shares converted into common stock										1,000
Series F Preferred Stock [Member]
Shares issued for license							$ 864,000
Temporary equity, shares authorized										1,000		1,000
Conversion of convertible shares				1,000			1,000
Temporary equity description					the conversion rate for each share of Series F Preferred Stock was amended to equal (i)(a) 4.84% multiplied by, (b) the Fully-Diluted shares as of the Approval Date (each as defined in the Series F Certificate), divided by (ii) the total number of shares of Series F Preferred Stock, (iii) rounded to the nearest thousandths place. The total number of Fully-Diluted Shares is set as of, and can not change after the Approval Date. Based on the full-diluted shares outstanding, this equated to 192,073,017 shares of Common Stock on the Approval Date. Fully-Diluted means the aggregate of (A) the total number of shares of Common Stock outstanding as of such date, (B) the number of shares of Common Stock (including all such Common Stock equivalents) into which all Convertible Securities outstanding as of such date could be converted or exercised, and (C) the number of shares of Common Stock (including all such Common Stock equivalents) issuable upon exercise of all options outstanding as of such date of exercise, divided by 0.9516.
Temporary equity, shares outstanding										0		0
Temporary equity, stated value										$ 0.001		$ 0.001
Temporary equity, stated value										$ 1		$ 1
Common stock, par value							$ 0.0045
Series G Preferred Stock [Member]
Number of shares issued										4,600
Shares issued for license										$ 1,000
Temporary equity, shares authorized						4,600				4,600		4,600
Temporary equity stated value per share						$ 1,000
Conversion of convertible shares			4,600
Temporary equity description					the conversion rate for each share of Series G Preferred Stock was amended to equal (i)(a) 6.45% multiplied by, (b) the Fully-Diluted shares as of the Approval Date (each as defined in the Series G Certificate, divided by (ii) the total number of shares of Series G Preferred Stock, (iii) rounded to the nearest thousandths place. The total number of Fully-Diluted Shares is set as of, and does not change after the Approval Date. Based on the current fully-diluted shares outstanding, this equated to 255,555,556 shares of common stock on the Approval Date. Fully-Diluted means the aggregate of (A) the total number of shares of Common Stock outstanding as of such date, (B) the number of shares of Common Stock (including all such Common Stock equivalents) into which all Convertible Securities outstanding as of such date could be converted or exercised, and (C) the number of shares of Common Stock (including all such Common Stock equivalents) issuable upon exercise of all options outstanding as of such date of exercise, divided by 0.9355.
Temporary equity, shares outstanding										0		0
Temporary equity, stated value										$ 0.001		$ 0.001
Temporary equity, stated value										$ 1,000		$ 1,000
Temporary equity, value, subscriptions										$ 4,600,000
Series G Preferred Stock [Member] | Minimum [Member]
Debt instrument conversion percentage						4.99%
Series G Preferred Stock [Member] | Maximum [Member]
Debt instrument conversion percentage						9.90%
Series H Preferred Stock [Member]
Temporary equity, shares authorized		39,895								39,895		39,895
Voting rights, description		Shares of Series H Preferred Stock have no voting rights and are senior in dividend rights and liquidation preference to our Common Stock and all other Common Stock Equivalents. Each share of Series H Preferred Stock may be converted into 1,000 shares of Common Stock, subject to a maximum ownership limit of 9.99%.
Temporary equity, shares outstanding										39,895		39,895
Temporary equity, stated value		$ 1								$ 0.001		$ 0.001
Temporary equity, stated value										$ 1		$ 1
Series H Preferred Stock [Member] | Exchange Agreement [Member]
Conversion of shares	39,895
Number of shares issued	39,895
Conversion of shares	$ 3,989,500

For the three months ended Marc

For the three months ended March 31, 2023, a summary of our warrant activity is as follows: (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate intrinsic value, issued
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants, balance, beginning of year | shares	246,173,016
Weighted average exercise price, beginning of year | $ / shares	$ 0.021
Weighted average life excercised (in years)	4 years 1 month 16 days
Weighted average grant date fair value, beginning of period	$ 399,783
Aggregate intrinsic value , beginning balance	$ 4,431,114
Weighted average exercise price, issued | $ / shares	$ 0.020
Weighted average life (years), issued	4 years 1 month 16 days
Weighted average grant date fair value, issued
Aggregate intrinsic value, issued
Number of warrants, balance, end of period | shares	286,173,016
Weighted average exercise price, ending of year | $ / shares	$ 0.021
Weighted average life excercised (in years)	4 years 1 month 16 days
Weighted average grant date fair value, end of period	$ 343,904
Aggregate intrinsic value, ending balance	$ 4,431,114
Warrant [Member] | February Seventeen Twenty Twenty One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants, issued | shares	40,000,000

Shareholders_ Equity (Details N

Shareholders’ Equity (Details Narrative) - USD ($)			3 Months Ended	12 Months Ended
	Jan. 10, 2024	Jul. 17, 2020	Mar. 31, 2023	Feb. 17, 2022	Dec. 31, 2022	Apr. 27, 2022
Class of Stock [Line Items]
Preferred stock, shares authorized			50,000,000		50,000,000
Preferred stock, shares designated			48,617,400		48,617,400
Common stock, shares outstanding			1,603,095,243		1,603,095,243
Common stock per share			$ 0.02
Common Stock [Member]
Class of Stock [Line Items]
Common stock per share						$ 0.018
Subsequent Event [Member] | Common Stock [Member]
Class of Stock [Line Items]
Common stock per share	$ 0.02
Subsequent Event [Member] | Unsecured Convertible Notes Payable [Member]
Class of Stock [Line Items]
Proceeds from unsecured notes payable	$ 220,000
Subsequent Event [Member] | Unsecured Convertible Notes Payable [Member] | Common Stock [Member]
Class of Stock [Line Items]
Warrants purchase	40,000,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			100
Preferred stock, voting rights		Although the Series B Preferred Stock is entitled to 51% voting rights as described above, the stock has no dividend rate nor conversion feature.	Holders of Series B Preferred Stock have the right to vote on all shareholder matters equal to 51% of the total voting power of each class of stock outstanding. Holders of shares of Series B Preferred are entitled to such 51% voting rights regardless of the number of voting shares issued by the company at any time.
Preferred stock, shares outstanding			100		100
Series B Preferred Stock [Member] | Mr. Canouse [Member]
Class of Stock [Line Items]
Conversion of shares				100
Series B Preferred Stock [Member] | License Agreement [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized		100

Schedule of Previous Year Asset

Schedule of Previous Year Assets Liabilities and Expenses (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Current assets		$ 342,264
Property, equipment and right-of-use assets		2,823,224
Intangible assets		12,027,769
Total Assets		15,193,257
Accounts payable and accrued liabilities		620,306
Lease liability obligations		1,468,233
Total Liabilities		2,088,539
Revenues	163,473	474,999
Selling, general and administrative	(9,886)	(134,589)
Television operation		(87,632)
Amortization		(80,494)
Professional fees		(201,336)
Interest expense		(2,904)
Gain (loss) on asset disposals	6,695,083	(52,668)
Impairment loss
Gain (loss) from discontinued operations	$ (6,521,724)	$ (84,624)

Schedule of Income Tax Expense

Schedule of Income Tax Expense (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Net loss for the three-month period	$ (10,768,418)	$ (2,536,688)	$ 13,139,810
Statutory and effective tax rates	21%	21%
Income taxes expenses (recovery) at the effective rate	$ 2	$ (532,704)
Effect of change in tax rates
Permanent differences
Valuation allowance	2,261,368	532,704
Income tax expense and income tax liability

Schedule of Deferred Income Tax

Schedule of Deferred Income Tax Asset (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Tax loss carried forward
Deferred tax assets	5,020,728	2,759,360
Valuation allowance	(5,020,728)	(2,759,360)
Deferred taxes recognized

Income Taxes (Details Narrative

Income Taxes (Details Narrative) $ in Millions	Mar. 31, 2023 USD ($)
Expire In Twenty Thirty Nine [Member]
Operating Loss Carryforwards [Line Items]
Tax losses	$ 30
Expire in Twenty Forty [Member]
Operating Loss Carryforwards [Line Items]
Tax losses	$ 30

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($)	Nov. 10, 2023	Sep. 21, 2023	Feb. 18, 2024
Subsequent Event [Line Items]
Other subsequent description	On November 10, 2023, Philip Falcone, individually and on behalf of the Company and other named defendants, filed a Confession of Judgment affirming that a promissory note (the “Z4 Note”) had been issued by the Company, dated December 28, 2021, by Z4 MGMT LLC (“Z4”), which was guaranteed by each of FFO1 2021 Irrevocable Trust and FFO2 2021 Irrevocable Trust. The Z4 Note was initially payable on February 15, 2022, and had an original principal balance of $500,000 with an interest rate of 12% per annum. The Z4 Note’s expiration date was extended to July 5, 2022, then further extended to March 31, 2023, and as of October 1, 2023, the revised principal balance, along with interest accrued, totaled $581,304. On such date, Z4 filed an Affidavit of Default affirming that the Z4 Note was in default and requesting a judgment in the amount of $581,304 against the Company, FFO1 2021 Irrevocable Trust, FFO2 2021 Irrevocable Trust, and Mr. Falcone personally, in favor of Z4.
Accrued interest and collection fees			$ 190,444
Accrued interest, penalties and fees			$ 3,500,000
Common Stock [Member]
Subsequent Event [Line Items]
Shares converted		1,152,500,000